ストックスクリーナーアプリを入手
28.51
4.90%
-1.47
前日終値:
$29.98
開ける：
$31
24時間の取引高:
30,212
Relative Volume:
0.65
時価総額：
$1.28B
収益：
$9.74M
当期純損益:
$7.19M
株価収益率:
174.16
EPS:
0.1637
ネットキャッシュフロー:
$2.25M
1週間 パフォーマンス:
+3.94%
1か月 パフォーマンス:
+9.05%
6か月 パフォーマンス:
+74.27%
1年 パフォーマンス:
+333.94%
1日の値動き範囲:
$29.00
$32.70
1週間の範囲:
$28.00
$32.94
52週間の値動き範囲:
$6.34
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Compare NNNN vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
29.20 | 1.28B | 9.74M | 7.19M | 2.25M | 0.1637 |
ISRG
Intuitive Surgical Inc
|
452.14 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
43.25 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
66.17 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
209.70 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Anbio Biotechnology (NNNN) 最新ニュース
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
Why Anbio Biotechnology Class A Shares Are Jumping - TipRanks
Free cash flow per share of Anbio Biotechnology Class A – FWB:N3B - TradingView
Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance Overhaul - TipRanks
Anbio Biotechnology (NNNN) seeks huge capital increase and 500-vote Class B shares - Stock Titan
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat
Why Anbio Biotechnology Shares Are Suddenly Surging - TipRanks
Anbio (NNNN) Stock Volume Drop (Buying Pressure) 2026-04-22Trending Buy Opportunities - Newser
Anbio Biotechnology posts solid FY25 results, diversifies portfolio - MSN
Cany Xu Net Worth (2026) - GuruFocus
Nancy Hartzler Net Worth (2026) - GuruFocus
Suki Song Net Worth (2026) - GuruFocus
Michael Lau Net Worth (2026) - GuruFocus
Chris Tian Net Worth (2026) - GuruFocus
Why Anbio Biotechnology Shares Are Sliding Fast - TipRanks
Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.5%Here's What Happened - MarketBeat
Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple - simplywall.st
Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile - Sahm
Is Anbio (NNNN) Stock Discounted Now | Price at $27.63, Up 1.96%Verified Stock Signals - Newser
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio - Sahm
Is Anbio (NNNN) Stock Good for Beginners | Price at $26.77, Down 0.28%Verified Stock Signals - Newser
Form 20-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] - ADVFN
Discovering US Undiscovered Gems for April 2026 - simplywall.st
Anbio Biotechnology (NNNN) files 20-F/A to mark well-known seasoned issuer - Stock Titan
Anbio Biotechnology (ANBF) Non Cash 74.1% Net Margin Fuels Fresh Debate On Earnings Quality - simplywall.st
Anbio Biotechnology | 3: Initial statement of beneficial ownership of securities- Hartzler Nancy - Moomoo
Anbio Biotechnology (NNNN) CEO Michael Lau identified as insider in Form 3 - Stock Titan
Anbio Biotechnology (NNNN) director XU CANY files initial Form 3 - Stock Titan
Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks
Super-voting control and post-COVID shift at Anbio Biotechnology (Nasdaq: NNNN) - Stock Titan
Anbio Biotechnology Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Will Anbio (NNNN) Stock Hit New Highs | Price at $26.40, Up 2.13%Community Trade Ideas - Newser
Exxon Mobil, Pepsico among market cap stock movers on Monday - Investing.com UK
Exxon Mobil, Pepsico among market cap stock movers on Monday By Investing.com - Investing.com Canada
Anbio Biotechnology (NNNN) Surges 11.6% Intraday – What’s Fueling the Volatility? - Bitget
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum - The Manila Times
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum on March 17, 2026 - geneonline.com
Anbio CEO to outline rapid diagnostic plans at KeyBanc investor event - Stock Titan
Aktis Oncology (AKTS) Stock Analysis Report | Financials & Insights - Benzinga Japan
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World
Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today
Anbio Biotechnology falls -5.8% - MSN
Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge
Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World
TechTarget (TTGT) to Release Earnings on Wednesday - Defense World
Anbio Biotechnology (NNNN) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
1.24%
大文字化:
|
ボリューム (24 時間):